Patients with COVID-19 Presenting with Acute Pancreatitis (Non-Necrotizing)
Author | Date of publication | Country | Sex | Age (yr) | Comorbidity | Mode of COVID-19 diagnosis | Mode of pancreatitis diagnosis | Treatment | Outcome |
---|---|---|---|---|---|---|---|---|---|
Meireles et al8 | May 2020 | Portugal | Female | 36 | HTN, ESRD | RT-PCR | Biochemical markers | Conservative management | Alive |
Aloysius et al9 | 20 Jul 2020 | USA | Female | 36 | Obesity | RT-PCR | Biochemical markers and abdominal CT | Conservative management | Alive |
Anand et al10 | Jun 2020 | UK | Female | 59 | Thrombophilia, history of cholecystectomy | RT-PCR | Abdominal CT | Conservative management | Alive |
Hadi et al11 | 20 Jun 2020 | Denmark | Female | 47 | None | RT-PCR | Biochemical markers and ultrasound | Invasive ventilation | N/A |
Denmark | Female | 68 | HTN, hyperthyroidism | RT-PCR | Biochemical markers | Invasive ventilation | N/A | ||
Gadiparthi et al12 | 23 Jun 2020 | USA | Male | 40 | None | RT-PCR | Abdominal CT | Intensive care admission and conservative management | Alive |
Suchman et al13 | 2 Jan 2021 | USA | N/A | N/A | None | RT-PCR | Biochemical markers, clinical | Conservative management | Alive |
Female | N/A | None | RT-PCR | Biochemical markers, clinical | Conservative management | Alive | |||
Stevens et al14 | Nov 2020 | USA | Female | 10 | Obesity, asthma | RT-PCR | Abdominal CT | Intensive care admission and IV Immunoglobulins | Alive |
Shinohara et al15 | Nov 2020 | Japan | Male | 58 | HTN | RT-PCR | Abdominal CT | Conservative management (antibiotics and steroids), ECMO | Alive |
Kataria et al16 | Jul 2020 | Pakistan | Female | 49 | None | RT-PCR | Biochemical markers | Conservative management with antibiotics | Alive |
Meyers et al17 | Nov 2020 | USA | Male | 67 | HTN, alcoholism | RT-PCR | Biochemical markers | Conservative management | Alive |
Cheung et al18 | Aug 2020 | USA | Male | 38 | None | RT-PCR | Biochemical markers and abdominal CT | Conservative management | Alive |
Kandasamy et al19 | Nov 2020 | India | Female | 45 | None | RT-PCR | Abdominal CT | Conservative management | Alive |
Jespersen Nizamic et al20 | Dec 2021 | USA | Female | 49 | CKD, renal transplant—on immunosuppressants | RT-PCR | Abdominal CT | Conservative management including tacrolimus | Alive |
Narang et al21 | Mar 2021 | USA | Female | 20 | Pregnant, obesity, history of cholecystectomy | RT-PCR | MRCP | Steroids, preterm induction of labor | Alive |
Gonzalo-Voltas et al22 | Aug 2020 | Spain | Female | 76 | Smoker, hypercholesterolemia | RT-PCR | Biochemical markers and abdominal CT | Conservative management | Alive |
Lakshmanan and Malik23 | Aug 2020 | USA | Male | 68 | ESRD, HTN, DM | RT-PCR | Abdominal CT | Conservative management | Alive |
Simou et al24 | Oct 2020 | Morocco | N/A | 67 | DM, obesity, alcoholism, history of cholecystectomy | RT-PCR | Abdominal CT | Invasive ventilation | Expired |
Wang et al25 | Aug 2020 | China | Male | 42 | None | RT-PCR | Biochemical markers and abdominal CT | Invasive ventilation | Expired |
China | Male | 35 | None | RT-PCR | Biochemical markers and abdominal CT | Conservative management | Alive | ||
Brikman et al26 | Jul 2020 | Israel | Male | 61 | None | RT-PCR | Biochemical markers and abdominal CT | Conservative management | Alive |
Tollard et al27 | Mar 2021 | France | Female | 32 | Obesity, DM, DKA | RT-PCR | Biochemical markers and abdominal CT | Conservative management | Expired |
Acherjya et al28 | Oct 2020 | Bangladesh | Female | 57 | HTN, DM, breast cancer, and laryngeal cancer—receiving radiation and chemotherapy | RT-PCR | Abdominal CT | Conservative management | Alive |
Karimzadeh et al29 | Jun 2020 | Iran | Female | 65 | HTN, Asthma | RT-PCR | Clinical and biochemical diagnosis | Conservative management | Alive |
Mazrouei et al30 | Jun 2020 | UAE | Male | 24 | None | RT-PCR | Abdominal CT | Conservative management | Alive |
Samies et al31 | Feb 2021 | USA | Male | 15 | None | RT-PCR | Biochemical markers | Conservative management | Alive |
USA | Male | 11 | None | RT-PCR | Biochemical markers and abdominal CT | Conservative management | Alive | ||
USA | Female | 16 | History of pancreatitis | RT-PCR | Biochemical markers and abdominal CT | Conservative management | Alive | ||
Alwaeli et al32 | Nov 2020 | USA | Male | 30 | None | RT-PCR | Biochemical markers and abdominal CT | Conservative management including TPN | Alive |
Purayil et al33 | Aug 2020 | Qatar | Male | 58 | None | RT-PCR | Clinical and biochemical diagnosis | Conservative management | Alive |
Rabice et al34 | May 2020 | USA | Female | 36 | Pregnant, obese, DM, pre-eclampsia | RT-PCR | Clinical and biochemical diagnosis | Conservative management | Alive |
Patnaik et al35 | Sep 2020 | India | Male | 29 | None | RT-PCR | Biochemical markers and abdominal CT | Conservative management including antibiotics | Alive |
Pinte and Baicus36 | Jun 2020 | Romania | Male | 47 | None | RT-PCR | Abdominal CT | Conservative management | Alive |
Alves et al37 | Sep 2020 | Brazil | Female | 56 | HTN | RT-PCR | MRCP | Intensive care management | Alive |
Ibrahim et al38 | Oct 2020 | Qatar | Male | 36 | None | RT-PCR | Abdominal CT | Intensive care management plus hemodialysis | N/A |
Miao et al39 | Jul 2020 | France | Female | 26 | None | RT-PCR | Abdominal CT | Conservative management | Alive |
Bokhari and Mahmood40 | Sep 2020 | Pakistan | Male | 32 | None | RT-PCR | Biochemical markers and abdominal CT | Conservative management | Alive |
Hassani et al41 | 2020 | Iran | Female | 78 | HTN, IHD | RT-PCR | Clinical and biochemical diagnosis | Invasive ventilation | Expired |
UAE, United Arab Emirates; HTN, hypertension; ESRD, end-stage renal disease; CKD, chronic kidney disease; DM, diabetes mellitus; IHD, ischemic heart disease; DKA; diabetic ketoacidosis; RT-PCR, reverse transcription polymerase chain reaction; CT, computed tomography; MRCP, magnetic resonance cholangiopancreatography; ECMO, extracorporeal membrane oxygenation; TPN, total parenteral nutrition; N/A, not available.